Modern Water Share Discussion Threads

[tewkesbury] 25/3/2020 07:45

18/3/2020

Simon Humphrey, CEO of Modern Water, commented:

"This Agreement is a water-shed moment for Modern Water. We are moving from a self-contained production, sales, marketing and distribution company to a collaborative, cooperation and partnership business model. This immediately gives Modern Water access to state-of-the art laboratories in the UK without the need for capital expenditure. Integumen's superior development and manufacturing capabilities will enable us rapidly to grow our existing network of sales, marketing and distribution channels, delivering the quality of product we are synonymous with, whilst lowering operational costs."

Gerard Brandon, CEO of Integumen, commented:

"We are delighted to announce the continued expansion of our laboratories and to be able to provide European bacteria reagent manufacturing capacity and logistic support to Modern Water's sales, marketing and distribution in the US, EU, China and Japan. In addition to production of the bacteria reagents, our AI division is exploring options to develop data analytic tools for Modern Water's monitoring equipment, with the potential to add higher-value bolt-on real-time alert services leading to increased revenue per client."

[timberwolf3] 24/3/2020 20:46

COVID 19 and Modern Water Group
Modern water and wastewater treatment systems play an important role in public health protection. With the potential for environmental transmission, water and wastewater operators need to know the potential for survival of this type of virus in water and wastewater treatment systems.

Coronaviruses, named for the crown-like spikes on their surface, were first identified in the mid-1960s. Currently, seven coronaviruses are known to infect people and make them ill. Three of these — MERS-CoV, SARS-CoV, and COVID-19 — emerged in the last 20 years and are examples of how some coronaviruses that infect animals can evolve to infect humans. COVID-19 is a new variety of coronavirus and is an enveloped, single-stranded (positive-sense) RNA virus.

So, what is the fate of coronavirus in sewage and wastewater treatment plants? Or in the aquatic environment? And should we be worried about the efficacy of water treatment filtration and disinfection processes for coronavirus removal and inactivation?

The short answer: No — if we take proper precautions and risk considerations.

The long answer: This is a new virus without an extensive body of literature on the effectiveness of water and wastewater treatment processes. And real-life experiences will vary due to water quality and treatment plant details.

According to a 2008 University of Arizona study, coronaviruses have not been found to be more resistant to water treatment than other microorganisms such as E. coli, phage, or poliovirus — which are commonly used as surrogates for treatment performance evaluations. Results from bench-scale studies suggest that the survival of coronaviruses is temperature dependent, with greater survival at lower temperatures. Therefore, coronavirus is expected to be reduced in raw wastewater and surface waters in warmer seasons.

How is it transmitted?

Human viruses do not replicate in the environment. For a coronavirus to be transferred via the water cycle, it must have the ability to survive in human waste, retain its infectivity, and come in contact with another person — most likely via aerosols. Findings suggest that COVID-19 can be transmitted through human waste.

Should a major virus pandemic occur, wastewater and drinking water treatment industries would face increased scrutiny. Utilities would need to respond rapidly to minimize occupational and public health risks based on the available evidence. Wastewater effluents would possibly impact recreation, irrigation, and drinking waters. While wastewater treatment does reduce virus levels, infective human viruses are often detected in wastewater treatment plant effluent.

Information for wastewater treatment plant operators

Typically, human waste entering a sewage system is carried through an underground pipe system to a municipal treatment plant. Wastewater treatment plants receiving sewage from hospitals and isolation centers treating coronavirus patients — and domestic sewage from areas of known l

[timberwolf3] 24/3/2020 19:04

If this gets linked officially in the fight against covid 19, this will multibag.

[tewkesbury] 24/3/2020 14:31

gjbrandon
28 Feb '20 - 13:41 - 2783 of 2800

This might be interesting. Modern Water have a backlog of equipment to be shipped to China

Ministry of Ecology and Environment?MEE? of the PRC has just released the emergency environmental monitoring program for the novel coronavirus epidemic, stressing the following:

1. Environmental departments at all levels must pay extra attention to drinking water source monitoring and early warning. On top of the regular water parameters, emergency parameters such as acute toxicity and free chlorine will be added to the water monitoring program.

2. Environmental departments must work closely to ensure normal operation of all air and surface water monitoring stations.
3. Emergency monitoring plans will be further revised, reserves of emergency supplies will be increased in case of contamination events and secondary disasters.

hxxp://www.mee.gov.cn/xxgk2018/xxgk/xxgk15/202001/t20200131_761095.html

[sharetalk] 24/3/2020 11:27

Hello tewkesbury. Improved outlook for Modern Water.

[tewkesbury] 24/3/2020 10:10

Looks good again.

[tickboo] 19/3/2020 10:50

One would think its products will be in demand and good news it can scale the manufacturing up without adding costs. A win/win for both businesses. With an improved sales/marketing channels too one would think sales will ramp up. Given the cash in the bank, the $665,000 orders to fulfil the market cap is way to low. Wish I had spare funds to buy more here.

[worried faith] 19/3/2020 07:44

It would seem a sensible action to take if they were unable to fulfil these orders on their own. They get 60% of the profit on the order backlog instead of zero when the customers cancel their orders. Plus it gives confidence to customers in the future. There is a question as to why they got in this state, but that is for another day. Right now, they need to win some more orders and announce them as they win them. What is happening on the sales and new order side of things?

[garth] 19/3/2020 06:59

Its just a helping hand to fulfill their existing order backlog. And they get to keep 60% after costs.

G.

[argylerich] 19/3/2020 06:50

It's not a contract win. Read the RNS

[aimtrader2] 18/3/2020 22:58

Only the seller kept us down today and overhang. Would have bagged in better market. Huge contract win today. Lots more contracts to come too.

[tickboo] 18/3/2020 12:31

Modern Water plcModern Water, the global water crisis monitoring and solutions provider, has announced its signing of a three-year revenue sharing manufacturing agency agreement (the 'Agreement') with Integumen plc (AIM:SKIN, 'Integumen'). This will provide manufacturing and logistical support for the Company's supply of water monitoring reagent consumables.The Agreement is structured in expectation of receiving revenues of US$1.25m (£1.04m*) per year for each of the next 3 years, totalling US$3.75m (£3.12m*). This is then shared between the two, based on a 60%/40% split in favour of Modern Water (after costs) and is subject to rolling 12-month extensions thereafter. The Company has been producing its own bacteria-based products for existing customers to use as consumables in their monitoring equipment. Product demand has shown consistent, organic growth of c. 5% per year from its client base, although past balance sheet constraints have meant that it had been forced to rely on somewhat outdated equipment which, in turn had resulted in capacity constraints while also occasionally testing required quality standards.The news is a further important step emanating from MWG's February 2020 proposal to modernise its operations along with a Board-level reorganisation, which was then followed by the appointment of Integumen and Cellulac plc's CEO, Mr Gerard Brandon, as non-executive director and Chairman. The common factor between Modern Water and Integumen is their expertise in handling and managing bacteria; Integumen, for example, has been developing such products for the past 12 years with specific expertise in viruses and toxins through its Labskin subsidiary. Here it produces full thickness human skin equivalent; it incorporates fully differentiated dermal and epidermal components that functionally model skin for the purpose of clinical research and testing.Effectively a watershed moment for Modern Water, the Agreement reflects its intention to move from a self-contained production, sales, marketing and distribution operation, to a collaborative, cooperation and partnership business model. It immediately provides the Company with access to state-of-the-art UK laboratories, together with their experienced scientists, without the need for capital expenditure or the extended time required to bring such a team together. Integumen's superior development and manufacturing capabilities should enable MWG to build rapidly upon its existing network of sales, marketing and distribution channels, delivering clients the product quality and quantity demanded through a lower operational cost base. Integumen has already announced a further 100% expansion of its purpose-built product and development laboratories in York, UK, to 6,000 square feet, adding six more laboratory rooms to meet growing demand. Two of those laboratories will be allocated to the production of Modern Water's bacteria reagent. As part of this Agreement, a further three full-time laboratory technicians will be recruited to join Integumen's team of highly skilled scientific specialists in bacteria, virus and toxins.2020 to date has seen Modern Water implement significant operational change whilealsobroadeningitscorporatevision. Operatinginanareaofhighinternationalgrowthits consumable reagents have historically enjoyed gross margins as high as 83%.Today's news confirms it has not only secured access to increased production capacityto service its expanding global opportunity, but also that it has the option to co-developbolt-on real-time detection of contamination in water using the Rinocloud AI bacterialand viral infection tests using its RAWTest AI solution. Presenting cross-sellingopportunities across the two companies' respective sales, marketing and distributionchannels, its recent participation in the Integumen-led ecowaterOS consortium alsorecognises the urgent international need for an end-to-end water contamination,detection and decontamination provider network, that offers the ability to providecustomers with real-time monitoring solutions. Altogether, recent news reflects thenew dynamism that has been injected into the Company through its recentreorganisation, in terms of ambition, product offering and customer targeting.*Assumes £-US$1.20

[iamgreat1] 18/3/2020 12:02

No it is not

[1kiwi] 18/3/2020 08:27

BAGER AHOY, WHAT AN RNS! A Carlsburgh RNS indeed!

[backtogo] 12/3/2020 14:53

0.1p soon. You are all about to be bummed.

[escapetohome] 11/3/2020 11:27

UP, NICE. STILL GOT ALL MY SHARES.

[gbenson1] 11/3/2020 11:17

Nice buying interest in the last hour, is something about to drop??

[pieball] 02/3/2020 19:53

No, I got it wrong. Sunup have shares in MWG. But the joint venture company was or is called "Encyclo" .. oh well!

"The joint venture, which has an initial term of 20 years, is conditional upon (i) completion of the subscription by Sunup referred to below, and (ii) the joint venture company, Encyclo Water Technology (Zhejiang) Co., Ltd ("Encyclo"), being granted an extendable business licence ("Business Licence") by the PRC State Administration for Industry & Commerce. "

[worried faith] 28/2/2020 15:12

When are the annual results coming out?

[flashheart] 28/2/2020 13:48

Good afternoon GB. As a holder of both (more heavily of SKIN), would you see this development having a greater positive impact on MWG or SKIN or both equally. {Under a bit of temporary pressure over there by the way from what appears to be a distressed seller}

[worried faith] 27/2/2020 13:27

Thanks, Parsons4, I might just buy some more.

[parsons4] 27/2/2020 08:24

worried faith, far be it for me to give advice. No there are no more shares available at .5p. But there is a chance that the price will come down to nearer the placing price, providing there is not a very bullish RNS (unlikely in the near term I would say). Gerald Brandon has put personal money into MWG and I believe he has had success in the past. It would not cost you a fortune to double up at nearer .5 and bring your average right down. That's what I would do, but I am a believer in GB !!!! Good luck